NCT00942474
Withdrawn
N/A
A Prospective, Non Randomized, Single-center, Non-blinded Feasibility Study Examining the Use of a Nerve Access Tool
ConditionsCystocele
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cystocele
- Sponsor
- MedtronicNeuro
- Primary Endpoint
- Electromyography Response
- Status
- Withdrawn
- Last Updated
- 12 years ago
Overview
Brief Summary
The purpose of this study is to assess the ability of the nerve access tool to facilitate nerve stimulation lead placement.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Subject is equal to or greater than 18 years of age
- •Subject has a diagnosis of cystocele with planned surgical repair
- •Subject has no known deficit of the nerve
- •Subject is willing and able to provide written informed consent and HIPAA authorization to participate by signing the Informed Consent/Health Insurance Portability and Accountability Act Form after a full explanation of the nature and purpose of this study
- •Subject is willing and able to comply with the study protocol
Exclusion Criteria
- •Subject has known neurological abnormalities of the nerve
- •Subject has a known allergy to the tool or neurostimulation lead components
- •Subject is pregnant or lactating
Outcomes
Primary Outcomes
Electromyography Response
Time Frame: Implant
Similar Trials
Completed
Early Phase 1
Selective Nerve Stimulation (SNS) Pilot StudyHealthyPainNCT01259271Codman & Shurtleff60
Completed
N/A
Clinical Trial to Study a Non-invasive Neurostimulation Device on Urgency (Urinary) Incontinence Overactive Bladder (OAB)Overactive BladderNCT01125722Ethicon Endo-Surgery74
Completed
N/A
Safety of Noninvasive Electrical Stimulation of Acupuncture Points (NESAP) in InfantsPainNCT01495286University of Arkansas30
Terminated
N/A
SubQStim: A Post-market Study of Subcutaneous Nerve Stimulation in Failed Back Surgery Syndrome (FBSS) PatientsFailed Back Surgery SyndromeNCT01711619MedtronicNeuro162
Not Yet Recruiting
N/A
Peripheral Nerve Stimulation Therapy for Atrial FibrillationAtrial FibrillationNCT05653583Cala Health, Inc.30